MiR-7-5p as a Diagnostic and Monitoring Biomarker for Neuroendocrine Tumors
MiR-7-5p demonstrates substantial potential as a non-invasive biomarker for diagnosing and monitoring NET. Our findings support its potential as a diagnostic tool and for assessing disease progression, offering a new avenue for early detection and treatment evaluation in patients with NET.
Authors
- Katsutoshi Shoda (ORCID: https://orcid.org/0000-0002-1011-5579)
- Suguru Maruyama (ORCID: https://orcid.org/0000-0002-9926-7463)
- Daisuke Ichikawa (ORCID: https://orcid.org/0000-0002-1467-5119)
- Ryo Saito (ORCID: https://orcid.org/0000-0002-7580-3567)
- Kensuke Shiraishi
- Atsushi Shiozaki (ORCID: https://orcid.org/0000-0003-3739-160X)
- Hirotaka Konishi (ORCID: https://orcid.org/0000-0002-4899-8944)
- Rie Shibata (ORCID: https://orcid.org/0009-0004-9462-5964)
- Yudai Higuchi (ORCID: https://orcid.org/0009-0009-7453-0630)
- Takashi Nakayama (ORCID: https://orcid.org/0000-0002-8493-899X)
- Yoshihiko Kawaguchi
- Shinji Furuya
- Hidetake Amemiya
Institutions
- Kyoto Prefectural University of Medicine (JP)
- University of Yamanashi Hospital (JP)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1097/sla.0000000000006816
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00